WallStreetZenWallStreetZen

NASDAQ: LXEO
Lexeo Therapeutics Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Lexeo Therapeutics earnings were -$98.3M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. The latest LXEO earnings report on Dec 31, 2024 announced Q4 2024 earnings of -$25.9M, down 12.1% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, LXEO reported annual earnings of -$98.3M, with 48.1% growth.

LXEO earnings history

Current Revenue
$0.0
Current Earnings
-$98.3M
Current Profit Margin
0%

LXEO Return on Equity

Current Company
-65.1%
Current Industry
-2%
Current Market
34.1%
LXEO's Return on Equity (-65.1%)... subscribe to Premium to read more.
High Return on Equity Performance

LXEO undefined

Current Company
-54.2%
Current Industry
-0.4%
LXEO is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when LXEO announces earnings.

LXEO undefined

Current Company
-79.13%
Current Industry
5.9%
LXEO's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

LXEO vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
LXEO-$96.19M-$98.33MN/A-$3.09
NMRA-$239.69M-$243.79MN/A-$1.53
TIL-$61.32M-$74.14MN/A-$11.39
OBIO-$60.06M-$61.02MN/A-$1.66
CSBR$8.10M$6.43M+282.31%$0.47
View Top Biotech Stocks

Lexeo Therapeutics Earnings Reports & History FAQ

What were Lexeo Therapeutics's earnings last quarter?

Lexeo Therapeutics (NASDAQ: LXEO) reported Q4 2024 earnings per share (EPS) of -$0.78, up 103.93% year over year. Total LXEO earnings for the quarter were -$25.92 million. In the same quarter last year, Lexeo Therapeutics's earnings per share (EPS) was $19.84.

If you're new to stock investing, here's how to buy Lexeo Therapeutics stock.

Is Lexeo Therapeutics profitable or losing money?

As of the last Lexeo Therapeutics earnings report, Lexeo Therapeutics is currently losing money. Lexeo Therapeutics's net profit (also called net income) for the twelve months ending Dec 31, 2024 was -$98.33 million, a 48.11% increase year over year.

What was LXEO's earnings growth in the past year?

As of Lexeo Therapeutics's earnings date in Q2 2025, Lexeo Therapeutics's earnings has grown year over year. LXEO earnings in the past year totalled -$98.33 million.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.